Arch Therapeutics Inc (OTCQB:ARTH)

0.2825
Delayed Data
As of Apr 20
 -0.013 / -4.40%
Today’s Change
0.25
Today|||52-Week Range
0.89
-34.29%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Arch Therapeutics Inc have a median target of 2.42, with a high estimate of 3.00 and a low estimate of 1.85. The median estimate represents a +758.41% increase from the last price of 0.28.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Arch Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.01
Sales
$0.00
Reporting Date
May 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 30.00%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.